Adapting Appetites - Scientific and Industry Perspectives on the Rise of GLP-1 Medications
14 Oct 2025 | Kerry Health and Nutrition Institute
As the adoption of GLP-1 Receptor Agonists (GLP-1 RAs) rapidly accelerates, the food and beverage industry stands at the threshold of significant transformation. These breakthrough medications are reshaping not only individual health journeys but also consumer preferences and expectations. In response, manufacturers, product innovators, and nutrition professionals are urgently re-examining how to support evolving dietary patterns, nutritional needs, and purchasing behaviours.
Nutrition Consultant
VP Research and Development ProActive Health Food Protection and Preservation
Vice President Marketing North America
Angie Jefferson
Nutrition Consultant
Dr Alexandra Boelrijk
VP Research and Development ProActive Health Food Protection and Preservation
Elizabeth Horvath
Vice President Marketing North America
Mark Faherty
Senior Director External Corporate Affairs
Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Mark Faherty
Senior Director External Corporate Affairs
Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Angie Jefferson
Nutrition Consultant
Dr Alexandra Boelrijk
VP Research and Development ProActive Health Food Protection and Preservation
Elizabeth Horvath
Vice President Marketing North America
Mark Faherty
Senior Director External Corporate Affairs
Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Upcoming webinars
Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
AB-BIOTICS Kaneka Probiotics
Better gummies, better absorption: formulating gummies with organic mineral salts
Jungbunzlauer
Upliving with Postbiotics: Discover the power of LAC-Living+ in Mood
Morinaga Milk Industry Co., Ltd.
